Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.
Del Alcázar E, López-Ferrer A, Martínez-Doménech Á, Ruiz-Villaverde R, Llamas-Velasco MDM, Rocamora V, Julià M, Notario J, Fernández-Freire LR, Sahuquillo-Torralba A, Vidal D, Rivera R, Carretero G, Mateu A, de la Cueva P, Carrascosa JM. Del Alcázar E, et al. Among authors: de la cueva p. Dermatol Ther. 2022 Feb;35(2):e15231. doi: 10.1111/dth.15231. Epub 2022 Jan 17. Dermatol Ther. 2022. PMID: 34820971 Free article.
Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
Puig L, Carrascosa JM, Belinchón I, Fernández-Redondo V, Carretero G, Ruiz-Carrascosa JC, Careaga JM, de la Cueva P, Gárate MT, Ribera M; Panel de Expertos del Consenso Delphi sobre Tratamiento tópico de la psoriasis; Grupo de Psoriasis de la Academia Española de Dermatología y Venereología. Puig L, et al. Among authors: de la cueva p. Actas Dermosifiliogr. 2013 Jul-Aug;104(6):488-96. doi: 10.1016/j.ad.2012.12.005. Epub 2013 Feb 8. Actas Dermosifiliogr. 2013. PMID: 23395400 Free article. English, Spanish.
Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
Puig L, Carrascosa JM, Carretero G, de la Cueva P, Lafuente-Urrez RF, Belinchón I, Sánchez-Regaña M, García-Bustínduy M, Ribera M, Alsina M, Ferrándiz C, Fonseca E, García-Patos V, Herrera E, López-Estebaranz JL, Marrón SE, Moreno JC, Notario J, Rivera R, Rodriguez-Cerdeira C, Romero A, Ruiz-Villaverde R, Taberner R, Vidal D; Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Puig L, et al. Among authors: de la cueva p. Actas Dermosifiliogr. 2013 Oct;104(8):694-709. doi: 10.1016/j.adengl.2013.04.013. Epub 2013 Sep 7. Actas Dermosifiliogr. 2013. PMID: 24018211 Free article.
Expert recommendations on treating psoriasis in special circumstances.
Carrascosa JM, Belinchón I, de-la-Cueva P, Izu R, Luelmo J, Ruiz-Villaverde R. Carrascosa JM, et al. Among authors: de la cueva p. Actas Dermosifiliogr. 2015 May;106(4):292-309. doi: 10.1016/j.ad.2014.11.005. Epub 2015 Jan 14. Actas Dermosifiliogr. 2015. PMID: 25595327 Free article. Review. English, Spanish.
Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort.
García-Doval I, Pérez-Zafrilla B, Ferrandiz C, Carretero G, Daudén E, de la Cueva P, Gómez-García FJ, Herrera-Ceballos E, Belinchón-Romero I, Sánchez-Carazo JL, López-Estebaranz JL, Alsina M, Ferrán M, Torrado R, Carrascosa JM, Rivera R, Vanaclocha F; BIOBADADERM Study Group. García-Doval I, et al. Among authors: de la cueva p. J Dermatolog Treat. 2016;27(3):203-9. doi: 10.3109/09546634.2015.1088130. Epub 2015 Sep 25. J Dermatolog Treat. 2016. PMID: 26367799 Free article.
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations.
Carrascosa JM, de la Cueva P, Ara M, Puig L, Bordas X, Carretero G, Ferrándiz L, Sánchez-Carazo JL, Daudén E, López-Estebaranz JL, Vidal D, Herranz P, Jorquera E, Coto-Segura P, Ribera M. Carrascosa JM, et al. Among authors: de la cueva p. Actas Dermosifiliogr. 2016 Apr;107(3):194-206. doi: 10.1016/j.ad.2015.10.005. Epub 2015 Nov 21. Actas Dermosifiliogr. 2016. PMID: 26614486 Free article. Review. English, Spanish.
Reliability of the MDi Psoriasis® Application to Aid Therapeutic Decision-Making in Psoriasis.
Moreno-Ramírez D, Herrerías-Esteban JM, Ojeda-Vila T, Carrascosa JM, Carretero G, de la Cueva P, Ferrándiz C, Galán M, Rivera R, Rodríguez-Fernández L, Ruiz-Villaverde R, Ferrándiz L. Moreno-Ramírez D, et al. Among authors: de la cueva p. Actas Dermosifiliogr. 2017 Sep;108(7):650-656. doi: 10.1016/j.ad.2017.02.009. Epub 2017 Apr 4. Actas Dermosifiliogr. 2017. PMID: 28385425 Free article. English, Spanish.
Moderate Psoriasis: A Proposed Definition.
Llamas-Velasco M, de la Cueva P, Notario J, Martínez-Pilar L, Martorell A, Moreno-Ramírez D. Llamas-Velasco M, et al. Among authors: de la cueva p. Actas Dermosifiliogr. 2017 Dec;108(10):911-917. doi: 10.1016/j.ad.2017.07.002. Epub 2017 Aug 17. Actas Dermosifiliogr. 2017. PMID: 28823420 Free article. Review. English, Spanish.
120 results